Related Experiment Video
Updated: May 17, 2026

Exploring Arterial Smooth Muscle Kv7 Potassium Channel Function using Patch Clamp Electrophysiology and Pressure Myography
Published on: September 14, 2012
K(ATP) channels mediate the antihypertrophic effects afforded by κ-opioid receptor stimulation in neonatal rat
Lei Zhang1, Hongxin Wang, Meili Lu
1Key Laboratory of Molecular Biology and Drug Research, Liaoning Medical College, Jinzhou 121001, P.R. China ;
Abstract:
Recent evidence suggests that κ-opioid receptor (OR) agonists and K(ATP) channel activation exert antihypertrophic effects on cardiac myocytes. We studied the role of K(ATP) channels in the antihypertrophic effects of ORs in primary cultures of neonatal rat ventricular myocytes exposed for 48 h to the α(1) adrenoceptor agonist phenylephrine and the relative contributions of mitochondrial K(ATP) (mitoK(ATP)) and sarcolemmal K(ATP) (sarcK(ATP)). Furthermore, we elucidated the pathway between ORs and K(ATP) channels and their impact on intracellular Ca(2+) ([Ca(2+)](i)) transients. Hypertrophy of cardiomyocytes was characterized by increases in i) total protein content; ii) cell size and iii) [(3)H]leucine incorporation. Phenylephrine (10 μM) increased the three parameters. Trans-(±)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]-benzeneacetamid methanesulfonate salt (U50,488H), a selective κ-opioid receptor agonist, prevented phenylephrine-induced hypertrophy and [Ca(2+)](i) transients. The effect of U50,488H was abolished by nor-binaltorphimine, a selective κ-OR antagonist, indicating that the effect was κ-OR-mediated. The protein kinase C inhibitor chelerythrine and the K(ATP) channel inhibitors glibenclamide (50 μM), a nonselective K(ATP) antagonist, and 5-hydroxydecanoic acid (100 μM), a mitochondrial selective K(ATP) antagonist, reversed the antihypertrophic effect of U50,488H, and there was no significant difference between the two K(ATP) channel blockers. Moreover, we also determined the expression of the Kir6.2 subunits of the K(ATP) channel, which increased in response to U50,488H in the presence of phenylephrine, but was suppressed by chelerythrine, glibenclamide and 5-hydroxydecanoic acid. U50,488H also attenuated the elevation of [Ca(2+)](i). This study suggests that K(ATP), and particularly the mitochondrial K(ATP,) mediates the antihypertrophic effects of κ-opioid receptor stimulation via the PKC signaling pathway.
Insights
κ-opioid receptor (OR) agonists prevent cardiac hypertrophy by activating K(ATP) channels, particularly mitochondrial K(ATP) (mitoK(ATP)). This pathway involves protein kinase C (PKC) and reduces intracellular calcium transients.
Area of Science:
- Cardiology
- Pharmacology
- Molecular Biology
Background:
- Cardiac hypertrophy is a significant risk factor for heart failure.
- κ-opioid receptors (ORs) and K(ATP) channels are implicated in regulating cardiac myocyte function.
- Previous studies suggest potential antihypertrophic roles for both OR agonists and K(ATP) channel activation.
Purpose of the Study:
- To investigate the antihypertrophic effects of κ-opioid receptor (OR) agonists in neonatal rat ventricular myocytes.
- To determine the role of K(ATP) channels, including mitochondrial (mitoK(ATP)) and sarcolemmal (sarcK(ATP)) subtypes, in mediating these OR effects.
- To elucidate the signaling pathway connecting ORs, K(ATP) channels, and intracellular calcium ([Ca(2+)](i)) transients.
Main Methods:
- Primary cultures of neonatal rat ventricular myocytes were exposed to phenylephrine to induce hypertrophy.
- The effects of the selective κ-OR agonist U50,488H were assessed on hypertrophy markers (protein content, cell size, [(3)H]leucine incorporation) and [Ca(2+)](i) transients.
- Pharmacological inhibitors of κ-OR (nor-binaltorphimine), protein kinase C (chelerythrine), and K(ATP) channels (glibenclamide, 5-hydroxydecanoic acid) were used.
- Expression of Kir6.2 subunits of the K(ATP) channel was analyzed.
Main Results:
- Phenylephrine induced significant cardiac hypertrophy and elevated [Ca(2+)](i) transients.
- U50,488H, a κ-OR agonist, prevented phenylephrine-induced hypertrophy and normalized [Ca(2+)](i) transients, an effect blocked by nor-binaltorphimine.
- The antihypertrophic effect of U50,488H was reversed by K(ATP) channel inhibitors (glibenclamide and 5-hydroxydecanoic acid), with no significant difference between nonselective and mitoK(ATP) selective inhibitors.
- U50,488H increased Kir6.2 subunit expression, which was abrogated by inhibitors.
- The protein kinase C inhibitor chelerythrine also reversed the antihypertrophic effect of U50,488H.
Conclusions:
- κ-opioid receptor stimulation exerts antihypertrophic effects on cardiac myocytes.
- These effects are mediated by K(ATP) channels, with a significant contribution from mitochondrial K(ATP) (mitoK(ATP)).
- The protein kinase C (PKC) signaling pathway is involved in the cross-talk between κ-ORs and K(ATP) channels, ultimately impacting intracellular calcium levels.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
G-Protein Gated Ion Channels
Sensory organs,...
Opioid Receptors: Overview
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
